Papers

Peer-reviewed
2001

A survey on the drug therapy for delirium

Psychiatry and Clinical Neurosciences
  • Toshiyuki Someya
  • ,
  • Taro Endo
  • ,
  • Takashi Hara
  • ,
  • Gohei Yagi
  • ,
  • Jiro Suzuki

Volume
55
Number
4
First page
397
Last page
401
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1046/j.1440-1819.2001.00881.x

Delirium, which is experienced by 10-30% of inpatients, is commonly seen in daily practice. A survey was conducted of the delirium medications, and results were obtained from 28 psychiatric departments and related facilities. Haloperidol was used in 67% cases for the treatment of delirium. Ninety-seven per cent of facilities considered haloperidol as the drug of first choice, while 57% thought this drug had few side-effects and was easy to use. However, because the use of this drug is not covered by health insurance in Japan, its use is limited. We expect that this study on medication for the treatment of delirium will be a first step in increasing the approved indications for drugs used for the treatment of delirium, and to reduce off-label use.

Link information
DOI
https://doi.org/10.1046/j.1440-1819.2001.00881.x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/11442892
ID information
  • DOI : 10.1046/j.1440-1819.2001.00881.x
  • ISSN : 1323-1316
  • Pubmed ID : 11442892
  • SCOPUS ID : 0034890736

Export
BibTeX RIS